Management im Gesundheitswesen

Dr. Sabine Vogler

Sabine Vogler ist wissenschaftliche Mitarbeiterin in Teilzeit am Fachgebiet Management im Gesundheitswesen.

Hauptberuflich leitet Sabine Vogler die 2016 geschaffene Abteilung für Pharmaökonomie am österreichischen Public-Health Institut „Gesundheit Österreich GmbH“ (GÖG) in Wien. Zuvor war sie ab 2006 Themenschwerpunkt-Verantwortliche für Pharmaökonomie und Arzneimittelsystemforschung an der GÖG. Weiters ist sie Direktorin des seit 2010 an der GÖG eingerichteten WHO-Kooperationszentrums für Arzneimittelpreisbildung und -erstattung. Sie wirkte maßgeblich an der Gründung des Behördennetzwerks „Pharmaceutical Pricing and Reimbursement Information“ (PPRI) im Jahr 2005 mit.

Sabine Vogler ist promovierte Sozial- und Wirtschaftswissenschaftlerin. Vor ihrem Eintritt in das ÖBIG, die Vorgängerinstitution der GÖG, im Jahr 1995 arbeitete sie an der Abteilung für Sozialpolitik der Wirtschaftsuniversität Wien als Forschungsassistentin. Im Herbst 2017 war sie Visiting Fellow an der Universität Bologna.

Arbeitsschwerpunkte/Forschungsinteressen

  • Arzneimittelpolitikanalyse
  • Medikamentenpreise
  • vergleichende Arzneimittelsystemforschung
  • Arzneimittelpreisbildung und -erstattung
  • Health technology assessment (HTA)
  • Arzneimitteldistribution und öffentliche Beschaffung
  • Antibiotikaresistenz
  • (Preis-)transparenz

Publikationen (Auszug)

Publikationen (in Peer Review-Journals)

VOGLER, Sabine; Haasis, Manuel A.; van den Ham, Rianne; Humbert, Tifenn; Garner, Sarah; Suleman, Fatima: European collaborations on medicine and vaccine procurement. Bulletin of the World Health Organization 2021, 99(10):715-721

Jommi, Claudio; Addis, Antonio; Martini, Nello; Nicod, Elena; Pani, Marcello; Scopinaro, Annalisa; VOGLER, Sabine: Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework? Global & Regional Health Technology Assessment. 2021;8: 114-9

Moye-Holz, Daniela; VOGLER, Sabine: Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America. Applied Health Economics and Health Policy 2021. doi.org/10.1007/s40258-021-00670-4

VOGLER, Sabine; Schneider, Peter; Zuba, Martin; Busse, Reinhard; Panteli Dimitra: Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure. Frontiers in Pharmacology 2021; 12: 1479. doi.org/10.3389/fphar.2021.625296

VOGLER, Sabine; Zimmermann, Nina; Babar-Ud-Din Zaheer; Busse, Reinhard; Espin Balbino, Jaime, et al.: Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference. Journal of Pharmaceutical Policy and Practice 2021; 14(18

VOGLER, Sabine, Schneider, Peter; Lepuschütz, Lena: Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation. Cost Effectiveness and Resource Allocation 18, 51. doi.org/10.1186/s12962-020-00247-3

Gombocz, Margit; VOGLER, Sabine: Public spending on orphan medicines: a review of the literature. Journal of Pharmaceutical Policy and Practice. 2020;13(1): 66.

VOGLER, Sabine; Fischer, Stefan: How to address medicines shortages: Findings from a cross-sectional study of 24 countries. Health Policy 2020; 124(12): 1287-1296

Gamba, Simona; Pertile, Paolo; VOGLER, Sabine: The impact of managed entry agreements on pharmaceutical prices. Health Economics 2020; 29 (S1): 47-62

Rintoul, Andrew; Colbert, Allison; Garner, Sarah; Kotwani, Anita; VOGLER, Sabine; Bouvy, Jacoline, Hill, Andrew: Medicines with one seller and many buyers: strategies to increase the power of the payer. BMJ 2020; 369:m1705

Ferrario, Alexandra; Dedet, Guillaume; Humbert, Tifenn; VOGLER, Sabine; Suleman, Fatima; Pedersen Hanne: Strategies to achieve fairer prices for generic and biosimilar medicines. BMJ 2020; 368:l5444

VOGLER, Sabine: Il miglioramento dei processi, la cooperazione, l’evidenza e la trasparenza: i temi chiave per le proposte di riforma delle politiche sul prezzo e rimborso dei farmaci. (Title in English: Improvement of processes, cooperation, evidence and transparency: the key proposals for reforming pharmaceutical pricing and reimbursement policies). Politiche sanitarie 2019; 20(4):180-182

VOGLER, Sabine; Dedet Guillaume, Bak Pedersen, Hanne: Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries. Applied Health Economics and Health Policy 2019:17,803–816

VOGLER, Sabine; Schneider, Peter; Dedet, Guillaume; Bak Pedersen, Hanne: Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan. International Journal for Equity in Health. 2019;18(1):89

VOGLER, Sabine: Fair prices for medicines? Exploring competent authorities’ and public payers’ preferences on pharmaceutical policies. Empirica - Journal of European Economics 2019; 46(3), 443-469

VOGLER, Sabine; Schneider, Peter: Assessing Data Sources for Medicine Price Studies. International Journal of Technology Assessment in Health Care 2019; 35(2): 106-115

VOGLER, Sabine; Schneider, Peter; Zimmermann, Nina: Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. PharmacoEconomics – Open 2019; 3:303–309

Mardetko, Nika; Kos, Mitja; VOGLER, Sabine: Review of studies reporting actual prices for medicines. Expert review of pharmacoeconomics & outcomes research 2019; 19(2): 159-179

VOGLER, Sabine, de Rooij, Roger: Medication wasted – Contents and costs of medicines ending up in household garbage. In: Research in Social and Administrative Pharmacy 2018; 14(12): 1140-1146]

VOGLER, Sabine; Gombocz, Margit; Zimmermann, Nina. Tendering for off-patent outpatient medicines: lessons learned from experiences in Belgium, Denmark and the Netherlands. Journal of Pharmaceutical Health Services Research 2017;8 (3): 147–158

VOGLER, Sabine, Paterson Kenneth: Can Price Transparency Contribute to More Affordable Patient Access to Medicines? PharmacoEconomics Open 2017;1 (3): 145–147

Pauwels, Kim; Huys, Isabelle; VOGLER, Sabine; Casteels, Marc; Simoens, Steven. Managed Entry Agreements for oncology drugs: lessons from the European experience to inform the future. Frontiers in Pharmacology 2017; 8: 171

Morgan Steve, VOGLER Sabine, Wagner Anita K. Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia. Health Policy 2017;121(4):354–62

VOGLER, Sabine, Paris Valérie, Ferrario Alessandra, Wirtz Veronika J, de Joncheere Kees, Schneider Peter et al. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. Applied Health Economics and Health Policy 2017:1-15

Schneider Peter, Renner Anna, Bobek Julia, Vogler Sabine, Ostermann Herwig. Economic Evaluation of Minor Ailment Schemes (MAS). Gesundheitsökonomie & Qualitätsmanagement 2017;22(S 01): S23-S29

VOGLER, Sabine; Zimmermann, Nina; Babar, Zaheer-Ud-Din.: Price comparison of high-cost originator medicines in European countries. Expert Review of Pharmacoeconomics & Outcomes Research 2017;17(2):221-230

VOGLER, Sabine; Zimmermann, Nina; de Joncheere, Kees: Policy interventions related to medicines: survey of measures taken in European countries during 2010 – 2015. Health Policy 2016; 120(12): 1363-1377

Gammie, Todd; VOGLER, Sabine; Babar, Zaheer-Ud-Din: Economic Evaluation of Hospital and Community Pharmacy Services: A Review of the Literature (2010-2015). Annals of Pharmacotherapy 2017; 51(1)

Iyengar; Swathi; Tay-Teo; Kiu; VOGER, Sabine; Beyer, Peter; Wiktor, Stefan; de Joncheere, Kees; Hill, Sue: Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis. PLoS Med 2016; 13: 5, e1002032

Pani, Luca; Montilla, Simona; Németh, Gergely; Russo, Pietro; Viceconte, Giorgia; VOGLER, S.: Balancing Access to Medicines and Sustainability in Europe: an Analysis from the Network of Competent Authorities on Pricing and Reimbursement (CAPR). Pharmacological Research 2016; S1043-6618(16)30202-X

VOGLER, Sabine; Zimmermann, Nina; Habimana, Katharina. Stakeholder preferences about policy objectives and measures of pharmaceutical pricing and reimbursement. Health Policy and Technology 2017; 5(3): 213–225

VOGLER, Sabine; Zimmermann, Nina; Ferrario Alessandra; Wirtz, Veronika; de Joncheere, Kees; Pedersen; Hanne; Dedet, Guillaume; Babar; Zaheer-ud-Din. Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. Journal of Pharmaceutical Policy and Practice 2016;9(1): 1

VOGLER, Sabine; Vitry, Agnes; Babar; Zaheer-Ud-Din: Cancer drugs in 16 European countries, Australia and New Zealand: a cross-country price comparison study. Lancet Oncology 2016;17(1): 39-47

VOGLER, Sabine; Österle, August; Mayer, Susanne. Inequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries. International journal for equity in health 2015,14(1), 124

VOGLER, Sabine; Kilpatrick, Kate; Babar, Zaheer-Ud-Din: Analysis of Medicine Prices in New Zealand and 16 European Countries. Value in Health 2015, 18(4): 484-492

VOGLER, Sabine; Habimana, Katharina; Arts, Daniela: Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy 2014, 117(3): 311-327

Leopold, Christine; Mantel-Teeuwisse, Aukje; VOGLER, Sabine; Valkova, Silvia; de Joncheere, Kees, Leufkens, H.G.M.; Wagner, Anita; Ross-Degnan, Dennis; Laing, Richard: Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries. Bulletin of the World Health Organization 2014; 92 (9):630-640

Leopold, Christine; Zhang, Fang; Mantel-Teeuwisse, Aukje K.; VOGLER, Silvia; Valkova, Silvia; Ross-Degnan, Dennis; Wagner, Anita: Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses. International Journal for Equity in Health 2014; 13(53)

VOGLER, Sabine; Leopold, Christine; Zimmermann, Nina; Habl, Claudia; de Joncheere, Kees: The Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative-Experiences from engaging with pharmaceutical policy makers. Health Policy and Technology 2014, 3(2): 139-148

VOGLER, Sabine; Leopold, Christine; Zuidberg, Christel; Habl, Claudia: Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in Vienna. Journal of Pharmaceutical Policy and Practice 2014;7(1): 6

Leopold, Christine; VOGLER, Sabine; Habl, Claudia; Mantel-Teeuwisse, Aukje; Espin, Jaime: Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab. Health Policy 2013;113(3): 313–22.

VOGLER, Sabine; Zimmermann, Nina: How do regional sickness funds encourage more rational use of medicines, including the increase of generic uptake? A case study from Austria. Generics and Biosimilars Initiative Journal (GaBI Journal) 2013;2(2): 65-75

VOGLER, Sabine; Zimmermann, Nina; Habl, Claudia; Mazag, Jan: The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine prices. In: Cost Effectiveness and Resource Allocation 2013;11: 15

Leopold, Christine; Mantel-Teeuwisse, Aukje; VOGLER, Sabine; de Joncheere, Kees; Laing, Richard; Leufkens; H.G.M.: Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries. Health Policy 2013; 112: 209-16

Björkhem-Bergman, Linda; Andersén-Karlsson Eva; Laing, Richard; Diogene, Eduardo; Melien, Oyvind; Jirlow Marlena; Malmstörm, Richark E., VOGLER, Sabine; Godman, Brian; Gustaffson, Lars L.l.: Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. European Journal of Clinical Pharmacology 2013;69(1):73-8

VOGLER, Sabine; Zimmermann, Nina; Leopold, Christine; Habl, Claudia; Mazag, Jan: Discounts and Rebates Granted for Medicines for Hospital Use in Five European Countries. The Open Pharmacoeconomics & Health Economics Journal 2013; (5)

VOGLER, Sabine. How large are the differences between originator and generic prices? Analysis of five molecules in 16 European countries. Farmeconomia Health economics and therapeutic pathways. 2012;13 (Suppl 3):29-41

VOGLER, Sabine; Zimmermann, Nina. The potential of generics policies: more room for exploitation. PPRI Conference Report. Generics and Biosimilars Initiative Journal (GaBI Journal). 2012;1(3-4):146-9

VOGLER, Sabine; Zimmermann, Nina; Habl, Claudia; Piessnegger, Jutta; Bucsics, Anna. Discounts and rebates granted to public payers for medicines in European countries. Southern Med Review. 2012;5(1):38-46

VOGER, Sabine. The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries – an overview. Generics and Biosimilars Initiative (GaBI) Journal 2012;1(2):93-100

Leopold, Christine, VOGLER, Sabine, Mantel-Teeuwisse, Aukje; de Joncheere, Kees; Leufkens, H.G.M.; Laing, Richard. Differences in external price referencing in Europe - A descriptive overview. Health Policy 2012;104(1):50-60

VOGLER, Sabine; Zimmermann, Nina; Leopold, Christine; de Joncheere, Kees. Pharmaceutical policies in European countries in response to the global financial crisis. Southern Med Review 2011; 4: 22-32

VOGLER, Sabine; Habl, Claudia; Bogut, Martina; Voncina, Luka. Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States. Croatian Medical Journal 2011; 52: 183-97

VOGLER, Sabine; Espin, Jaime; Habl, Claudia. Pharmaceutical Pricing and Reimbursement Information (PPRI) – New PPRI analysis including Spain. Pharmaceutical Policy and Law 2009;11(3):213-34

Arts, Danielle; Habl, Claudia; Rosian, Ingrid, VOGLER, Sabine. Pharmaceutical Pricing and Reimbursement Information (PPRI): a European Union project. Italian Journal of Public Health. 2006;3(1):36-41

Walley, Tom; Folino-Gallo, Pietro; Barry, Michael; Bruzzone, Mario; Joncheere, Kees de; Rosian, Ingrid; Schröder, Helmut; Tilson, Lesley; VOGLER, Sabine. The EurMedStat proposals on indicators for price and utilisation. Italian Journal of Public Health. 2006;3(1):15-21

 

Weitere Publikationen

VOGLER, Sabine: Preisregulierungen im internationalen Vergleich. In: Schröder Helmut, Thürmann Petra, Telschow Carsten, Schröder Melanie, Busse Reinhard. Arzneimittel-Kompass 2021. Hochpreisige Arzneimittel – Herausforderung und Perspektiven. Springer: Berlin 2021, pp. 125-38

VOGLER Sabine; Schneider, Peter, Fischer, Stefan et al.: Preisvergleich ausgabenstarker Arzneispezialitäten 2019. Gesundheit Österreich: Wien, 2021

Fischer, Stefan; VOGLER, Sabine; Windisch, Friederike; Zimmermann, Nina: HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTI. VALUE-Dx, 2021

VOGLER, Sabine; Habimana, Katharina; Bauer, Eveli; Schneider, Peter, Haasis, Manuel Alexander: Assessment of Centralised Procurement of Medicines in Portugal. Gesundheit Österreich: Wien, 2021

VOGLER, Sabine; Habimana, Katharina; Fischer, Stefan; Haasis, Manuel Alexander: Novel policy options for reimbursement, pricing and procurement of AMR health technologies. Gesundheit Österreich: Wen 2021

VOGLER, Sabine; Zimmermann, Nina; Dedet, Guillaume; Lam, Janice; Bak Pedersen, Hanne: Pharmaceutical Pricing and Reimbursement Systems in Eastern Europe and Central Asia. WHO Regional Office for Europe: Copenhagen 2020

VOGLER, Sabine; Schneider, Peter; Panteli, Dimitra, Busse, Reinhard: Biosimilars in Deutschland und im europäischen Vergleich – Marktsteuerungsmechanismen und Einsparpotenziale. In: Schwabe, Ulrich; Ludwig, Wolf-Dieter (Hrsg.): Arzneiverordnungs-Report 2020. Springer: Berlin, Heidelberg 2020

VOGLER, Sabine; Haasis, Manuel Alexander; van den Ham, Rianne; Suleman, Fatima; Humbert, Tifenn; Garner, Sarah: Cross-country collaborations to improve access to medicines and vaccines in the WHO European Region. WHO Regional Office for Europe: Copenhagen 2020

VOGLER, Sabine; Fischer, Stefan: Lieferengpässe bei Arzneimitteln: Internationale Evidenz und Empfehlungen für Deutschland. Gesundheit Österreich: Wien 2020

VOGLER, Sabine: Gratulation mit Wunschliste - Europäischer Blick aus dem Nachbarland. In: Greiner, Wolfgang; Witte, Julian; Gensorowsky, Daniel; Pauge, Sophie: AMNOG-Report 2020. 10 Jahre AMNOG - Rückblick und Ausblick. Hrsg. Storms, Andreas. Medhochzwei: Bielefeld und Hamburg, 2020

VOGLER, Sabine. Medicines Pricing: Limitations of Existing Policies and New Models. In: Babar, Zaheer-Ud-Din (Hrsg.): Global Pharmaceutical Policy. Springer, 2020, 99-137

VOGLER, Sabine; Haasis, Manuel Alexander; Zimmermann, Nina: PPRI Report 2018 - Pharmaceutical pricing and reimbursement policies in 47 PPRI network member countries. WHO Collaborating Centre for Pricing and Reimbursement Policies, Gesundheit Österreich GmbH: Wien, 2019

VOGLER, Sabine. Schneider, Peter; Panteli, Dimitra; Busse; Reinhardt. Biosimilars in Deutschland und im europäischen Vergleich – Entwicklungen und Potenziale. In: Schwabe, Ulrich; Paffrath, Dieter; Ludwig, Wolf-Dieter; Klauber, Jürgen (Hrsg.): Arzneiverordnungs-Report 2019. Springer: Heidelberg, Köln, Berlin, 2019

VOGLER, Sabine; Haasis, Manuel Alexander; Zimmermann, Nina: PPRI Pharma Brief: Austria 2019. Pharmaceutical Pricing and Reimbursement Information (PPRI) Pharma Briefs Series. Gesundheit Österreich: Wien 2019

VOGLER, Sabine (Hrsg.): Medicine Price Surveys, Analyses and Comparisons. Evidence and Methodology Guidance. Elsevier, 2019

VOGLER, Sabine; Haasis, Manuel Alexander; Lam, Janice; Dedet, Guillaume; Bak Pedersen, Hanne. Medicines reimbursement policies in Europe. WHO Regional Office for Europe: Copenhagen, 2018

VOGLER, Sabine; Paris, Valérie, Panteli, Dimitra. Policy Brief: Ensuring access to medicines: How to redesign pricing, reimbursement and procurement? European Observatory on Health Systems and Policies of the WHO Regional Office for Europe, 2018

VOGLER, Sabine. Marktzugang, Erstattung und Preissetzung neuer patentgeschützter Arzneimittel in der Europäischen Union. In: Schwabe, Ulrich; Paffrath, Dieter; Ludwig, Wolf-Dieter; Klauber, Jürgen (Hrsg.). Arzneiverordnungs-Report 2018. Springer: Heidelberg, Köln, Berlin, 2018

VOGLER Sabine. Access to High-Cost Medicines in Europe. In: Babar, Zaheer-Ud-Din (Hrsg.). Equitable Access to High-Cost Pharmaceuticals. Elsevier; 2018. pp. 143-64

Schneider, Peter; VOGLER, Sabine; Zimmermann, Nina; Zuba, Martin. Preisvergleich ausgabenstarker Arzneispezialitäten 2017 - Wissenschaftlicher Ergebnisbericht. Gesundheit Österreich: Wien 2018

VOGLER Sabine. Kostenintensive Krebsmedikamente – Preise im internationalen Vergleich. In: Grandt Daniel, Schubert Ingrid. Arzneimittelreport 2017. Schriftenreihe zur Gesundheitsanalyse. Band 3. BARMER GEK. Köln, 2017. S. 252-267

Schneider Peter, VOGLER Sabine. Pharmaceutical pricing and reimbursement reform in Kyrgyzstan. WHO Regional Office for Europe: Copenhagen, 2016

Panteli, Dimitra; Arickx, Francis; Cleemput, Irina; Dedet, Guillaume; Eckhardt; Helene; Fogarty, Emer; Gerkens; Sophie; Henschke, Cornelia; Hislop, Jeniffer; Jommi, Claudio; Kaitelidou, Daphne; Kawalec, Pawel; Keskimäki, Ilmo; Kroneman; Madelon; Lopez Bastida, Julio; Pita Barros, Pedro; Ramsberg, Joakim; Schneider, Peter; Spillane Susan; Vogler, Sabine; Vuorenkoski, Lauri; Wallach Kildemoes, Helle; Wouters, Oliver; Busse, Reinhard. Pharmaceutical regulation in 15 European countries: Review. Health Systems in Transition, 2016; 18(5):1–118

VOGLER, Sabine; Martikainen, Jaana: Measurement of Drug Expenditure. In: Elsevier, Monique et al. (Hrsg.): Drug Utilization Research: Methods and Applications. Wiley-Blackwell. April 2016. DOI: 10.1002/9781118949740.ch8

VOGLER Sabine, Lepuschütz Lena Schneider Peter, Stühlinger Verena. Study on enhanced cross-country coordination in the area of pharmaceutical product pricing. Publications Office of the European Union: Brussels, 2016

VOGLER Sabine, Schneider Peter, Zimmermann Nina. Preisvergleich kostenintensiver Arzneimittel 2015. Gesundheit Österreich GmbH; Wien 2016

Ostermann, Herwig; Renner, Anna; Bobek, Julia; Schneider, Peter; VOGLER, Sabine: A cost/benefit analysis of self-care systems in the European Union. Commissioned by the European Commission; Brussels 2015

WHO Regional Office for Europe (Hrsg.): Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research. Copenhagen 2015

VOGLER, Sabine; Zimmermann, Nina; Habl, Claudia: Preisanalyse von 30 kostenintensiven Arzneispezialitäten in Österreich im Vergleich mit anderen europäischen Ländern. Gesundheit Österreich: Wien 2015

VOGLER, Sabine; Martikainen, Jaana: Pharmaceutical Pricing in Europe. In: Babar, Zaheer-Ud-Din (Hrsg.): Pharmaceutical Prices in the 21st Century. Springer: 2015. S. 343-370

VOGLER, Sabine; Zimmermann, Nina, Habimana, Katharina: Study of the policy mix for the reimbursement of medicinal products. Proposal for a best practice-based approach based on stakeholder assessment. Gesundheit Österreich Forschungs- und Planungs GmbH and SOGETI: Wien, 2014

VOGLER, Sabine. Liberalization in the Pharmacy Sector. Working Paper for the OECD Global Forum on Distribution. Paris 2014

Bouvy, Jacqueline; VOGLER, Sabine: Priority Medicine Report. Background Paper 8.3. Pricing and Reimbursement Policies: Impacts on Innovation. In: Kaplan, Warren, Wirtz, Veronika; Mantel Teuwisse, Aukje; Laing, Richard (Hrsg.): Priority medicines for Europe and the world - 2013 update. World Health Organisation: Geneva, 2013

VOGLER, Sabine; Arts, Danielle; Sandberger, Katharina. Impact of pharmacy deregulation and regulation in European countries. Gesundheit Österreich Forschungs- und Planungs GmbH: Wien 2012

VOGLER, Sabine; Leopold, Christine; Zimmermann, Nina. PHIS Hospital Pharma. Arzneimittelmanagement in Krankenanstalten. GÖG/ÖBIG: Wien 2011

Habl, Claudia; VOGLER, Sabine et al. Referenzpreise in Europa. Analyse und Umsetzungsvoraussetzungen für Österreich. ÖBIG FP: Wien, 2008

VOGLER, Sabine; Habl, Claudia; Leopold, Christine et al. PPRI Report. GÖG/ÖBIG: Wien 2008

VOGLER, Sabine; Arts, Danielle; Habl, Claudia; Leopold, Christine. Pharmaceutical Systems in the European Union 2006. Facts Sheets and Comparative Analysis. ÖBIG: Wien, 2006

VOGLER, Sabine; Arts, Danielle, Habl, Claudia: Community Pharmacy in Europe. ÖBIG FP: Wien, 2006

Habl, Claudia; VOGLER, Sabine et al.: Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States ÖBIG FP: Wien, 2006

Habl, C.; VOGLER, S.; Schnabel, E.: Öffentliche Ausgaben für Ausgaben für Prävention und Gesundheitsförderung in Österreich 2001. ÖBIG: Wien, 2005

VOGLER, Sabine, Antony, Katja: Arzneimittelmittelsysteme in den neuen EU-Mitgliedstaaten. ÖBIG: Wien, 2005

Rosian, Ingrid; VOGLER, Sabine: Internationale Arzneimittelpreisvergleiche. Meta-Analyse, ÖBIG: Wien, 2004

VOGLER, Sabine; Freihoff, Wilhelm: Kostenfaktoren in der tierärztlichen Hausapotheke. ÖBIG: Wien, 2003

VOGLER, Sabine; Habl, Claudia: Arzneimittel. Distribution in Skandinavien. ÖBIG: Wien, 2003

Rosian, Ingrid; Mildschuh, Stephan; VOGLER, Sabine; Winkler, Petra: Selbstbeteiligung. Internationaler Vergleich und Implikationen für Österreich. ÖBIG: Wien, 2003

Rosian, Ingrid; VOGLER, Sabine: Generika - Modell Burgenland. ÖBIG: Wien, 2001

Rosian, Ingrid; Habl, Claudia; VOGLER, Sabine; Weigl, Marion: Arzneimittelausgaben. Strategien zur Kostendämpfung in der Europäischen Union. ÖBIG: Wien, 2001

Rosian, Ingrid; Habl, Claudia; VOGLER, Sabine. Innovation im Arzneimittelmarkt. Frankreich, Großbritannien, Italien: In: J. Klauber, H. Schröder, G.W. Selke (Hrsg.): Innovation im Arzneimittelmarkt. Springer: Berlin Heidelberg, 2000

Rosian, Ingrid; Habl, Claudia; VOGLER, Sabine; Weigl, Marion: Arzneimittelausgaben. Strategien zur Kostendämpfung in der EU. ÖBIG: Wien, 2001

VOGLER, Sabine; Habl, Claudia: E-Pharma, Arzneimittelvertrieb im Internet. ÖBIG: Wien, 2000

Rosian, Ingrid; VOGLER, Sabine; Weigl, Marion: Generika. ÖBIG: Wien, 2000

VOGLER, Sabine; Habl, Claudia. Gesundheitssysteme in Mittel- und Osteuropa / Health Care Systems in Central and Eastern Europe. ÖBIG: Wien, 1999

VOGLER, Sabine; Habl, Claudia; Kranvogel, Edith; Rosian, Ingrid. Arzneimittel. Vertrieb in Europa. ÖBIG. Wien 1998

Rosian, Ingrid; Rohrbach, Christa; Schindler, Eva; VOGLER, Sabine; Weigl, Marion: Biotechnologie. Pharmazeutische Industrie und Forschung in Österreich. ÖBIG: Wien 1998

Rosian, Ingrid; Habl, Claudia; VOGLER, Sabine: Arzneimittel. Steuerung der Märkte in neun europäischen Ländern / Pharmaceuticals. Market Control in Nine European Countries. ÖBIG: Wien 1998

Bronneberg, Gertrud; Frank Wilhelm; Pochobradsky, Elisabeth; VOGLER, Sabine: Arbeitssituation. Ambulante Pflege- und Sozialdienste Wiens. ÖBIG: Wien, 1997

Kux, S., VOGLER, S.: Außergerichtliche Durchsetzung von Patientenrechten. ÖBIG: Wien 1996

Badelt, Christoph; Holzmann, Andrea; Matul, Christian; Hofer, Helmut; VOGLER, Sabine et al.: Kosten der Pflegesicherung. Strukturen und Entwicklungstrends der Altenbetreuung. 2. Auflage, Böhlau: Wien, 1995

VOGLER, Sabine: Substitutionsbeziehungen zwischen Altersheim und ambulanter Altenpflege. Wien, 1995 (Dissertation)

VOGLER, Sabine. Ökonomische Aspekte der stationären Altenpflege unter besonderer Berücksichtigung des Zusammenhanges zwischen Pflegebedürftigkeit und Personalkosten. Wien, 1992 (Diplomarbeit)

Lehre am MiG

  • Wintersemester: Blended Learning Weiterbildungskurs Health Technology Assessment
  • Sommersemester: Modul „Systematische Bewertung medizinischer Technologien“ (HTA-online)

Mitgliedschaften (Auswahl)

  • European Drug Utilization Research Group (EuroDURG) Executive Committee, EuroDURG Focal Point für Österreich
  • Österreichische Pharmakologische Gesellschaft (APHAR)
  • International Health Economics Association (IHEA)
  • Austrian Health Economics Association (ATHEA), Rechnungsprüferin
  • Italian Health Economics Assocation (Associazione Italiana di Economia Sanitaria, AIES)
  • Piperska-Gruppe
  • Expert Panel of the WHO Guideline on Pharmaceutical Pricing Policies (2011-2013, Co-Chair des Expert Panel bei dessen Aktualisierung 2019/2020)

Herausgeberschaften und Mitgliedschaften in Editorial Boards

Herausgabe eines Buches

VOGLER, Sabine (Ed.): Medicine Price Surveys, Analyses and Comparisons. Evidence and Methodology Guidance. 1st Edition, Elsevier. 2018

 

Editorial Boards

Mitglied im International Advisory Board und Section Editor of Pharmaceutical Policy and Practice” (JOPPP)

Associate Editor bei „Cost-Effectiveness and Resource Allocation“ (CERA)

Associate Editor bei „BMC Health Services Research”

Mitglied im Editorial Board von „Pharmacoeconomics – Open”

Mitglied im Editorial Board des „Generics and Biosimilars Initiative (GaBI)”-Journals

 

Reviews

Reviewerin bei mehreren Journals (e.g. Applied Health Economics and Health Policy; BMJ; Clinical Therapeutics; European Journal of Health Economics; Health Economics, Policy and Law; Health Policy; Lancet; JAMA; Pharmacoeconomics; PLOS One, Social Science and Medicine, Value in Health)

Auszeichnung

2019 Helen Clark-JoPPP (Journal of Pharmaceutical Policy and Pratice) Award